While intermediate size FGF14<250 repeats are not considered pathogenic, and this sample size is too small for significance, further reporting across a range of repeat sizes with meta-analysis may yet reveal some relationship with MSA susceptibility. This evidence concerns the gene FGF14 and multiple system atrophy.